Molecular and Physiological Properties of Clonidine‐Displacing Substance

Annals of the New York Academy of Sciences

Volumn 763, Issue 1, 1995, Pages 314-324

  ATLAS, DAPHNE ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; CLONIDINE; CLONIDINE DISPLACING SUBSTANCE; FLUORESCAMINE; GUANIDINE; IMIDAZOLINE; IMIDAZOLINE RECEPTOR; NINHYDRIN; ORGANIC SOLVENT;

ARTERIAL PRESSURE; BINDING AFFINITY; BRAIN; BRAIN MEMBRANE; CATTLE; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CHEMICAL ANALYSIS; CONFERENCE PAPER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOLATION PROCEDURE; LIVER MEMBRANE; MASS SPECTROMETRY; MOLECULAR WEIGHT; NEUROTRANSMISSION; NONHUMAN; PLACENTA; PURIFICATION; SERUM; THROMBOCYTE; URINE;

BOS TAURUS; BOVINAE;

EID: 0029142549     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1995.tb32417.x     Document Type: Article

References (33)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. Isolation of an endogenous clonidine displacing substance from rat brain
3. Isolation and partial purification of a clonidine displacing substance
4. The brain's own clonidine; Purification and characterization of an endogenous clonidine displacing substance
5. Identifying clonidine‐displacing substance
6. An endogenous noncatecholamine Clonidine antagonist increases mean arterial pressure
7. Central cardiovascular effects of a non‐catecholamine endogenous ligand for clonidine receptors
8. An endogenous displacing substance from bovine brain: Receptor binding and hypotensive actions at the ventrolateral medulla
9. An endogenous brain substance CDS (clonidine displacing substance) inhibits the twitch response in rat vas deferens
10. 2‐adrenergic receptors of human platelets
11. Human plasma‐derived material with clonidine displacing substance (CDS)‐like properties contracts the isolated rat aorta
12. 2‐adrenergic agonists
13. Central cardiovascular effects of alpha adrenergic drugs: Differences between catecholamines and imidazolines
14. 2 adrenoceptors in the ventrolateral medulla
15. An endogenous substance with clonidine like properties: Selective binding to imidazoline sites in the ventrolateral medulla
16. 2 adrenergic receptor
17. Further characterization of the guinea pig cerebral cortex idazoxan receptor: Solubilization, distinction from the imidazole site, and demonstration of cirazoline as an idazoxan receptor‐selective drug
18. 2‐adrenergic receptor
19. 2 adrenergic receptors
20. Imidazoline binding sites in human placenta: Evidence for heterogeneity and a search for physiological function
21. 1‐imidazoline sites in bovine adrenal medullary membranes
22. 2 adrenoceptors and imidazoline binding sites in rat brain
23. Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in rat brain
24. Visualization of multiple imidazoline/guanidinium‐receptive sites
25. 2 adrenoceptors: More subtypes but fewer functional differences
26. Agmatine: An endogenous clonidine‐displacing substance in the brain
27. Raised levels of an endogenous non‐adrenergic substance in serum of pregnancy‐induced hypertension patients
28. Plasma desorption mass spectrometry
29. Detection and measurement of an endogenous clonidine‐displacing‐substance (CDS)
30. Detection and measurement of an endogenous clonidine‐displacing‐substance (CDS) in human cerebrospinal fluid (CSF)
31. Imidazoline guanidine receptive site in renal proximal tubule: Asymmetric distribution, regulation by cations and interaction with an endogenous clonidine displacing substance
32. 3H] idazoxan in rat brain
33. Is imidazoline site a unique receptor? A correlation with clonidine‐displacing‐substance activity